CN103013946B - Cordyceps sinensis hexadecane coenzyme A hydrolytic enzyme, gene and applications of hydrolytic enzyme and gene - Google Patents
Cordyceps sinensis hexadecane coenzyme A hydrolytic enzyme, gene and applications of hydrolytic enzyme and gene Download PDFInfo
- Publication number
- CN103013946B CN103013946B CN201210492892.2A CN201210492892A CN103013946B CN 103013946 B CN103013946 B CN 103013946B CN 201210492892 A CN201210492892 A CN 201210492892A CN 103013946 B CN103013946 B CN 103013946B
- Authority
- CN
- China
- Prior art keywords
- hexadecane
- gene
- coenzyme
- hydrolytic enzyme
- unsg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 title claims abstract description 104
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 51
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 title claims abstract description 20
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 title claims abstract description 20
- 239000005516 coenzyme A Substances 0.000 title claims abstract description 20
- 229940093530 coenzyme a Drugs 0.000 title claims abstract description 20
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 title claims abstract description 20
- 241001248610 Ophiocordyceps sinensis Species 0.000 title abstract description 30
- 102000004190 Enzymes Human genes 0.000 title abstract description 24
- 108090000790 Enzymes Proteins 0.000 title abstract description 24
- 230000003301 hydrolyzing effect Effects 0.000 title abstract 9
- 241000894006 Bacteria Species 0.000 claims abstract description 42
- DVSZKTAMJJTWFG-UHFFFAOYSA-N docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCCC=CC=CC=CC=CC=CC=CC(O)=O DVSZKTAMJJTWFG-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000002773 nucleotide Substances 0.000 claims abstract description 10
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 10
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 230000015572 biosynthetic process Effects 0.000 claims description 20
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 20
- GLCGEJFIZRSXBL-UHFFFAOYSA-N dodeca-1,3,5,7,9,11-hexaene Chemical compound C=CC=CC=CC=CC=CC=C GLCGEJFIZRSXBL-UHFFFAOYSA-N 0.000 claims description 12
- 238000010353 genetic engineering Methods 0.000 claims description 2
- 108020004414 DNA Proteins 0.000 abstract description 9
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 230000037353 metabolic pathway Effects 0.000 abstract description 3
- 230000002194 synthesizing effect Effects 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 238000010361 transduction Methods 0.000 abstract description 2
- 230000026683 transduction Effects 0.000 abstract description 2
- 230000009466 transformation Effects 0.000 abstract description 2
- 102000053602 DNA Human genes 0.000 abstract 2
- 230000001851 biosynthetic effect Effects 0.000 abstract 1
- 238000010367 cloning Methods 0.000 abstract 1
- 108090000604 Hydrolases Proteins 0.000 description 44
- 102000004157 Hydrolases Human genes 0.000 description 39
- 239000007788 liquid Substances 0.000 description 16
- 241000190633 Cordyceps Species 0.000 description 14
- 238000000034 method Methods 0.000 description 13
- 150000001413 amino acids Chemical group 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 241000672609 Escherichia coli BL21 Species 0.000 description 10
- 239000013612 plasmid Substances 0.000 description 10
- 241000588724 Escherichia coli Species 0.000 description 9
- 238000012408 PCR amplification Methods 0.000 description 9
- 238000001962 electrophoresis Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 239000002299 complementary DNA Substances 0.000 description 8
- 239000000499 gel Substances 0.000 description 8
- 230000004060 metabolic process Effects 0.000 description 8
- 230000037361 pathway Effects 0.000 description 8
- 108091033319 polynucleotide Proteins 0.000 description 8
- 102000040430 polynucleotide Human genes 0.000 description 8
- 239000002157 polynucleotide Substances 0.000 description 8
- 238000011160 research Methods 0.000 description 8
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 8
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 8
- 241000233866 Fungi Species 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 239000013613 expression plasmid Substances 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 6
- 240000001307 Myosotis scorpioides Species 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 108020004999 messenger RNA Proteins 0.000 description 6
- 238000003259 recombinant expression Methods 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 238000002525 ultrasonication Methods 0.000 description 6
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 239000002207 metabolite Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 238000010839 reverse transcription Methods 0.000 description 5
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000000137 annealing Methods 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 239000012159 carrier gas Substances 0.000 description 4
- 239000013599 cloning vector Substances 0.000 description 4
- 239000004567 concrete Substances 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000013604 expression vector Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000001502 gel electrophoresis Methods 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 241000255789 Bombyx mori Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 238000010805 cDNA synthesis kit Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 230000009849 deactivation Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 230000004129 fatty acid metabolism Effects 0.000 description 2
- 239000005350 fused silica glass Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000012160 loading buffer Substances 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 230000003071 parasitic effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000004853 protein function Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000012797 qualification Methods 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 229920002477 rna polymer Polymers 0.000 description 2
- 150000004671 saturated fatty acids Chemical class 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000009182 swimming Effects 0.000 description 2
- 239000006200 vaporizer Substances 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 102100022714 Acyl-coenzyme A thioesterase 13 Human genes 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 244000153158 Ammi visnaga Species 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 101100087393 Caenorhabditis elegans ran-2 gene Proteins 0.000 description 1
- 101000658635 Catharanthus roseus Tabersonine synthase Proteins 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241001464430 Cyanobacterium Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 108010087894 Fatty acid desaturases Proteins 0.000 description 1
- 102000009114 Fatty acid desaturases Human genes 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000130660 Hepialidae Species 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 241000255777 Lepidoptera Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000907999 Mortierella alpina Species 0.000 description 1
- 241000235395 Mucor Species 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 241000399350 Nitrolancea hollandica Lb Species 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 238000009004 PCR Kit Methods 0.000 description 1
- 108010035473 Palmitoyl-CoA Hydrolase Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 240000006698 Spigelia anthelmia Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- 241000330896 Thitarodes armoricanus Species 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 239000006035 Tryptophane Substances 0.000 description 1
- 240000001866 Vernicia fordii Species 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000003570 biosynthesizing effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 108010022240 delta-8 fatty acid desaturase Proteins 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000001456 gonadotroph Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 102000057593 human F8 Human genes 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000001915 proofreading effect Effects 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229940047431 recombinate Drugs 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention relates to a hexadecane coenzyme A hydrolytic enzyme synthesized from Bailing production bacterium cordyceps sinensis hirsutslla sinensis and docosahexaenic coenzyme A, a gene for coding the hexadecane coenzyme A hydrolytic enzyme and applications of the hydrolytic enzyme and the gene. The amino acid sequence of the hexadecane coenzyme A hydrolytic enzyme has above 90 percent of homology with a sequence shown in SEQ ID No.1 or SEQ ID No.3. According to the invention, the metabolic pathways of synthesizing the docosahexaenic acid by the hexadecane coenzyme A hydrolytic enzyme is researched in detail from the principle; cloning DNA (Deoxyribose Nucleic Acid) comprising the nucleotide sequence provided by the invention can be transferred into an engineering bacterium through transduction, transformation and transfer; through regulating the expression of a docosahexaenic acid biosynthetic gene, the high expressivity of the host hexadecane coenzyme A hydrolytic enzyme synthesized is endowed, and an effective path is provided for enlarging the yield of the docosahexaenic acid; and the hexadecane coenzyme A hydrolytic enzyme has an important application prospect.
Description
(1) technical field
The present invention relates to a kind of participation two dodecahexaene coenzyme A from " hundred makes " production bacterium Cordyceps sinensis China pilose spore to set out the n-Hexadecane Co A hydrolase (palmitoyl-CoA hydrolase) of anabolism docosahexenoic acid, the gene of this enzyme of encoding and application thereof.
(2) background technology
Cordyceps sinensis (Cordyceps sinensis (Berk.) Sacc.) is that Cordyceps fungus colonizes in the stroma on lepidopteran (Lepidoptera) Hepialidae insect (Hepialus armoricanus Oberthur) larva and the complex body (comprising stroma and polypide) on larva corpse.Cordyceps sinensis is traditional fungi herb resource that a class is treasured, and has the feature of meta-bolites and diverse biological activities, shows huge application and development prospect at biomedicine field.Cordyceps sinensis extensively, obviously receives much concern with its multiple medicinal efficacy, worldwide enjoys high praise.The traditional Chinese medical science is thought, Cordyceps sinensis enters lung kidney two warp, can tonifying lung cloudy, again can kidney-replenishing, cure mainly and suffer from a deficiency of the kidney, impotence and seminal emission, soreness of waist and knee joint, weak after being ill, chronic cough is weak, and phthisical cough phlegm blood, spontaneous sweating etc. are unique a kind of Chinese medicine that can balance simultaneously, regulate negative and positive.Modern pharmacology confirms, and Cordyceps sinensis has the biological activity widely such as immunomodulatory, antibacterial, antitumor, anti-oxidant, anti-ageing, hypoglycemic blood fat, gonadotropic Effect.
Cordyceps fungus is a kind of ascomycetes, has Conidial Stage (anamorph) and thecaspore stage (teleomorph) in its life history.And in the actual production such as artificial culture, liquid fermenting, use the Cordyceps fungus in imperfect stage, thus the qualification of Anamorph of Cordyceps Sinensis is extremely important.Chinese scholars is done a lot of work in Cordyceps Resources investigation, anamorph confirmation, activeconstituents compartment analysis and the mechanism of action, Application and Development.Cordyceps sinensis China pilose spore has been proved to be the anamorph existence form of Cordyceps sinensis, has the activeconstituents identical with natural cordyceps and drug effect.
Natural cs has strict parasitics and special ecotope, therefore its output is very low, and price is high.Wild cordyceps owing to restricting by factors such as growing environments, scarcity of resources.Owing to making little progress on artificial culture in recent years, the research of wild cordyceps surrogate focused mostly on liquid fermenting.Utilizing liquid submerged fermentation to cultivate Cordyceps mycelium, extract or fermented liquid, is a kind of effective way solving Cordyceps sinensis medicine source.Chinese caterpillar fungus fermentation produces Chinese caterpillar fungus substitute, both can these precious resources of available protecting Chinese caterpillar fungus, and the restriction that climate, geographical environment and Chinese caterpillar fungus parasitic conditions are not strict again, is suitable for industrialization scale operation.The substitute produced is as also similar to natural cs with drug effect in its composition of mycelium, is thus devoted to the fermentation culture of Cordyceps mycelium both at home and abroad always.The mycelia that aweto cultured by artificial fermentation China pilose spore obtains, through toxicity, pharmacology, plant research, prove with natural cs chemical constitution, pharmacological action basically identical, natural cs can be replaced to produce cordyceps product, to make up the shortage of natural resources, by the optimization to fermentation condition, the amount of mycelial biomass and meta-bolites is all significantly improved.
In recent years, along with the develop rapidly of natural product chemistry and modern chromatographic techniques, in worm grass product research and development, progressively turn to deeper functional metabolic Study on product by the direct utilization of Chinese caterpillar fungus raw material or crude extract.Large quantifier elimination is done to Chinese caterpillar fungus meta-bolites both at home and abroad, meta-bolites mainly comprises several large compounds such as nucleosides, polysaccharide, polypeptide, sterol, and wherein the representative research of functional metabolic product in biosynthesizing, pharmacological action etc. such as purines nucleosides, Cordyceps polysaccharide, N.F,USP MANNITOL wins initial success.
Unsaturated fatty acids refers to the lipid acid containing one or more double bond in molecule, and its fusing point comparatively saturated fatty acid is low.Unsaturated fatty acids is a kind of lipid acid forming body fat, and the lipid acid of needed by human, unsaturated fatty acids, according to the difference of double bond number, is divided into monounsaturated fatty acids and polyunsaturated fatty acid two kinds.Polyunsaturated fatty acid (Polyunsaturated Fatty Acids, PUFAs) relative saturation lipid acid has more effect, it can reduce blood cholesterol and triglyceride level, regulate heart function, reduce blood viscosity, improve blood microcirculation, improve the activity of brain cell, memory and thinking ability, strengthen the function etc. of human defensive system, in addition it can also be got rid of " rubbish " unnecessary in human body, namely owing to taking the photograph the superabundant fat that the excessive saturated fatty acid of people is formed, thus reaches the object of fat-reducing.Therefore, its potential medical pharmaceutical use receives the extensive concern in the world, causes the great attention of the industry such as food, medical even makeup.
Yung-Sheng in 1999 draws the △ 6 and △ 12 fatty acid dehydrogenase gene that have cloned Mortierella alpina (Mortiere Uaalpina) and expresses in yeast saccharomyces cerevisiae.2004, △ 3 desaturase in tung oil tree was proceeded to yeast by the people such as Dyer, successfully obtained and produced linolenic yeast.△ 12 desaturase of blue or green for algae bacterium (Cyanobacterium) is proceeded to potato by the people such as Maali-Amiri in 2007, successfully detects that potato fatty acid component there occurs considerable change.2008, △ 6 desaturase of volume branch Mucor turned in people's transgene tobacco by the people such as Hao, have successfully been obtained the bacterial strain of high yield gamma-linolenic acid.In addition, the relevant gene of many fatty acid desaturases is also had to be cloned and Transformation Application.Because most of desaturase is embrane-associated protein, its separation and purification is very difficult, and the desaturase that separation and purification is also identified cans be counted on one's fingers, and the research of the overwhelming majority is carried out around delta 8 desaturase genes and expression regulation thereof.
At present, the unsaturated fatty acids applied produces bacterium based on subtilis, and as the Cordyceps fungus of important anabolism unsaturated fatty acids, also only rest in the research of meta-bolites composition analysis and effect, also rarely found to the research of genes involved and albumen in Cordyceps fungus unsaturated fatty acids metabolic pathway of synthesizing.
(3) summary of the invention
The object of the invention is for the above deficiency that exists and the technical issues that need to address, the enzyme of bacterium Cordyceps sinensis China pilose spore anabolism docosahexenoic acid is produced to " hundred make " and encoding gene is furtherd investigate, provide " hundred makes " production bacterium Cordyceps sinensis China pilose spore and participate in two dodecahexaene coenzyme As and to set out the enzyme of anabolism docosahexenoic acid, encoding gene and application thereof.
The technical solution used in the present invention is:
Participate in two dodecahexaene coenzyme As to set out the n-Hexadecane Co A hydrolase of anabolism docosahexenoic acid, with sequence shown in SEQ ID No.1 or SEQ ID No.3, there is more than 90% homology; This enzyme can prepare corresponding docosahexenoic acid by catalysis two dodecahexaene coenzyme A.Due to the singularity of aminoacid sequence; the fragment of any peptide protein containing aminoacid sequence shown in SEQ ID NO.1 or SEQ ID No.3 or its variant; as its examples of conservative variations, bioactive fragment or derivative; as long as the fragment of this peptide protein or peptide protein variant and aforementioned amino acid sequences homology, more than 90%, all belong to the row of scope.Concrete described change can comprise amino acid whose disappearance, insertion or replacement in aminoacid sequence; Wherein, the conservative property for variant changes, and the amino acid replaced has the structure similar to original acid or chemical property, and as replaced Isoleucine with leucine, variant also can have non-conservation and change, as replaced glycine with tryptophane.
Preferably, described n-Hexadecane CoA hydrolase enzyme amino acid sequence such as SEQ ID No.1(is designated as unsG
1albumen) or SEQ ID No.3 shown in (be designated as unsG
2albumen).
N-Hexadecane Co A hydrolase of the present invention produces bacterium Cordyceps sinensis China pilose spore from " hundred make ".
The path being obtained corresponding docosahexenoic acid by two dodecahexaene coenzyme A anabolism is as follows:
The invention still further relates to described n-Hexadecane Co A hydrolase and prepare application in docosahexenoic acid at biocatalysis two dodecahexaene coenzyme A.
The invention still further relates to the encoding gene of above-mentioned n-Hexadecane Co A hydrolase, namely n-Hexadecane CoA hydrolase gene, concrete, and this encoding gene can be the gene order with polynucleotide shown in SEQ ID NO:2 or SEQ ID No.4 with more than 90% homology.Due to the singularity of nucleotide sequence, shown in any SEQ ID NO:2 or SEQ ID No.4, the variant of polynucleotide, as long as itself and this polynucleotide have more than 90% homology, all belongs to the row of scope.The variant of described polynucleotide refers to a kind of polynucleotide sequence having one or more Nucleotide and change.The variant of these polynucleotide can make raw displacement varient or the varient of non-life, comprises and replaces varient, Deletion variants and insertion varient.As known in the art, allelic variant is the replacement form of polynucleotide, and it may be the replacement of polynucleotide, disappearance or insertion, but can not from the function of peptide protein changing in fact its coding.
Preferably, described n-Hexadecane CoA hydrolase gene nucleotide sequence such as SEQ ID No.2(is designated as unsG
1gene) or SEQ ID No.4(be designated as unsG
2gene) shown in.
Described gene can be used for building can prepare the genetic engineering bacterium of docosahexenoic acid, to expand the output of docosahexenoic acid or derivatives thereof by biocatalysis two dodecahexaene coenzyme A.
Main points of the present invention there are provided the nucleotide sequence shown in the aminoacid sequence shown in SEQ ID NO:1 or 3 and SEQ ID NO:2 or 4, when this aminoacid sequence known and nucleotide sequence, the acquisition of this aminoacid sequence and nucleotide sequence, and related vector, host cell acquisition, be all apparent to those skilled in the art.
Beneficial effect of the present invention is mainly reflected in: the present invention studies in detail two dodecahexaene coenzyme A synthesis docosahexenoic acid pathways metabolisms principle, the cloned DNA comprising nucleotide sequence provided by the present invention can be used for proceeding in engineering bacteria by the method for transduction, conversion, Conjugative tiansfer, by regulating the expression of docosahexenoic acid biosynthesis gene, give the high expression level of host's n-Hexadecane Co A hydrolase, for the output expanding docosahexenoic acid or derivatives thereof provides effective way, there is major application prospect.
(4) accompanying drawing explanation
Fig. 1 is the denaturing formaldehyde gel electrophorogram that " hundred make " produces bacterium Cordyceps sinensis China pilose spore total serum IgE;
Fig. 2 is Fatty acid biosynthesis metabolism approach annotated map;
Fig. 3 is fatty acid metabolism approach annotated map;
Fig. 4 is unsaturated fatty acids metabolic pathway of synthesizing annotated map;
Fig. 5 is n-Hexadecane CoA hydrolase gene pcr amplification product gel electrophoresis figure;
Fig. 6 is cloning vector pMD18-T Vector and expression vector pET-28a physical map;
Fig. 7 is restructuring cloned plasmids pMD18-T/unsG physical map;
Fig. 8 is recombinant expression plasmid pET-28a/unsG building process schematic diagram;
Fig. 9 is recombinant expression plasmid pET-28a/unsG physical map;
Figure 10 is the SDS-PAGE figure of n-Hexadecane CoA hydrolase zymoprotein.
(5) embodiment
Below in conjunction with specific embodiment, the present invention is described further, but protection scope of the present invention is not limited in this:
Embodiment 1: " hundred make " produces the cultivation of bacterium Cordyceps sinensis China pilose spore
Bacterium source: first gather natural cordyceps from Qinghai, and taken back Hangzhou and carry out separation screening, obtain L0106 bacterial strain, and be China pilose spore (Hirsutella Sinensis) through this bacterial strain of strain identification, this culture presevation is in China typical culture collection center, deposit number is CCTCC No:M 2011278, discloses in the patent CN102373190A of previously application.
By this strain inoculation in inclined-plane, (this is the liquid formulations before solidification to culture medium prescription, by following proportions well after bevel again) be glucose 2.0%(w/v, 1% represents in 100mL substratum containing 1g, down together), Semen Maydis powder 1.0%, murphy juice 0.5%, dextrin 0.5%, yeast powder 0.5%, wheat bran 1.0%, dried silkworm chrysalis meal 2.0%, peptone 1.0%, magnesium sulfate 0.05%, potassium primary phosphate 0.05%, agar powder 1.0%, surplus is water, cultivates 25 days at 12 ~ 16 DEG C; Then by strain inoculation in fermention medium, culture medium prescription is glucose 1.0%, molasses 1.0%, dried silkworm chrysalis meal 0.5%, soybean cake powder 1.0%, yeast extract paste 0.5%, magnesium sulfate 0.01%, potassium primary phosphate 0.02%, surplus is water, be placed on shaking table, temperature 12 ~ 16 DEG C is cultivated 25 days, after cultivation terminates aseptically, carries out solid-liquid separation, and solid is placed in sterilized equipment, for subsequent use.
Embodiment 2: " hundred make " produces the extraction of bacterium Cordyceps sinensis China pilose spore total serum IgE
Total serum IgE is extracted with TRIzol reagent, step is specially: 1) liquid nitrogen grinding: get the new fresh thalli of 1g and put into mortar, repeatedly adding liquid nitrogen is fully ground to Powdered, be dispensed in the 1.5mL centrifuge tube of precooling, add 1mL TRIzol reagent, mixing, leaves standstill 5min on ice, nucleic acid-protein mixture is separated completely.2) RNA is separated: add 0.2mL chloroform, firmly concussion mixing 15s, and leave standstill 2 ~ 3min on ice, 4 DEG C, the centrifugal 15min of 12000rpm, layering, gets upper strata aqueous phase, about 600 μ L.3) RNA precipitation: add 500 μ L Virahols, leaving standstill 10min on ice, 4 DEG C, the centrifugal 10min of 12000rpm, abandon supernatant.4) RNA washing: add 1mL 75%(v/v) ethanol, hangs precipitation, leaves standstill 10min on ice, 4 DEG C, the centrifugal 15min of 7500rpm; Repeat washing step above, then wash one time.5) RNA is dissolved: be placed in by centrifuge tube and open wide dry 5 ~ 10min on ice, add appropriate DEPC water dissolution.
Embodiment 3: " hundred make " produces the order-checking of bacterium Cordyceps sinensis China pilose spore RNA sample
After extracting sample total serum IgE, with Oligo(dT) enrichment with magnetic bead mRNA.Add fragmentation buffer and mRNA is broken into short-movie section (200 ~ 700bp), take mRNA as template, Article 1 cDNA chain is synthesized with hexabasic base random primer (random hexamers), then Article 2 cDNA chain is synthesized, do end reparation after adding EB buffer solution elution through QiaQuick PCR kit purifying, add polyA and connect sequence measuring joints again, then clip size selection is carried out with agarose gel electrophoresis, finally carry out pcr amplification, the sequencing library Illumina GA IIx built up checks order.The raw image data obtained that checks order is converted into sequence data through base calling, i.e. raw data or raw reads.Only containing the reads of adaptor sequence in removing primitive sequencer reads, standby with subsequent analysis.
Embodiment 4: " hundred make " production bacterium Cordyceps sinensis China pilose spore RNA is short reads sequence assembling
Use short reads composite software SOAPdenovo(Li, Zhu et al. De novo assembly of human genomes with massively parallel short read sequencing [J]. Genome Res, 2010,20:265-272.) do transcript profile and from the beginning assemble.First the reads with certain length overlap is linked to be the longer Contig fragment not containing N by SOAPdenovo.Then Contig is returned in reads comparison, determine from the distance between the different Contig of same transcript and these Contig by paired-end reads, these Contig connect together by SOAPdenovo, and middle unknown nucleotide sequence N represents, so just obtains Scaffold.Utilize paired-end reads to do filling-up hole process to Scaffold further, finally obtain containing N minimum, the Unigene sequence that two ends can not extend again.Finally, Unigene sequence and albumen database nr, Swiss-Prot, KEGG and COG are done blastx comparison (evalue<0.00001), get the sequence direction that the best albumen of comparison result determines Unigene.If the comparison result between different sink is contradictory, then press nr, Swiss-Prot, the priority of KEGG and COG determines the sequence direction of Unigene, with above four storehouses all to less than Unigene software ESTScan(Iseli, Jongeneel et al. ESTScan:a program for detecting, evaluating, and reconstructing potential coding regions in EST sequences [J]. In Proceedings of 9th InternationalConference on Intelligent Systems for Molecular Biology. AAAIPress, Menlo Park, CA, pp. 1999, 138-148.) predict its coding region and determine the direction of sequence.For determining that the Unigene in sequence direction provides the sequence in its direction from 5' to 3', for determining the sequence that the Unigene in sequence direction provides composite software and obtains.
Embodiment 5: " hundred make " produces bacterium Cordyceps sinensis China pilose spore Unigene functional annotation
Functional annotation information provides the protein function annotation of Unigene, Pathway annotation, COG functional annotation and Gene Ontology(GO) functional annotation.First, by blastx by Unigene sequence alignment to albumen database nr, Swiss-Prot, KEGG and COG(evalue<0.00001), obtain the albumen with given Unigene with highest serial similarity, thus obtain the protein function annotation information of this Unigene.The Pathway annotation of Unigene can be obtained further according to KEGG annotation information.Compared by Unigene and COG database, the function that prediction Unigene is possible also does function statistic of classification to it.According to nr annotation information, use Blast2GO software (Conesa, Gotz et al. Blast2GO:a universal tool for annotation, visualization and analysis in functional genomics research [J]. Bioinformatics, 2005,21 (18): 3674-3676.) the GO annotation information of Unigene is obtained.After obtaining the GO annotation of each Unigene, with WEGO software (Ye, Fang et al. WEGO:a web tool for plotting GO annotations [J]. Nucleic Acids Research, 2006,34:293-297.) GO functional classification statistics is done, from the gene function distribution characteristics being macroscopically familiar with these species to all Unigene.
Embodiment 6: " hundred make " is produced bacterium Cordyceps sinensis China pilose spore docosahexenoic acid pathways metabolism and analyzed
Fig. 2 is the Fatty acid biosynthesis metabolism (map00061) in KEGG pathways metabolism annotation, Fig. 3 is the fatty acid metabolism (map00071) in KEGG pathways metabolism annotation, Fig. 4 is the unsaturated fatty acids anabolism (map01040) in KEGG pathways metabolism annotation, the enzyme annotated is that " hundred make " detected produces bacterium Cordyceps sinensis China pilose spore docosahexenoic acid pathways metabolism relevant enzymes, as can be seen from the figure, n-Hexadecane Co A hydrolase 2 Unigene from the corresponding docosahexenoic acid of two dodecahexaene coenzyme A synthesis are detected.By the ORF Finder software on-line checkingi in NCBI, have found the open reading frame (SEQ ID No.2, No.4) of this gene and obtain corresponding protein sequence (SEQ ID No.1, No.3).
Embodiment 7: " hundred make " produces bacterium Cordyceps sinensis China pilose spore n-Hexadecane CoA hydrolase gene design of primers
Use GENE RUNNER primer-design software according to predicting each gene open proofreading dna primers obtained, the n-Hexadecane CoA hydrolase gene of bacterium China pilose spore anabolism docosahexenoic acid is produced for clone's " hundred make ", primer by Shanghai Sheng Gong biotechnology company limited synthesize, primer sequence as follows listed by:
UnsG
1gene: forward primer 5 ' ATAGAATTCATGGTGAATGCGCGGCAGCC3 '
Reverse primer 5 ' ATAAAGCTTTCACCGCCCTGCGCTGCCC 3 '
UnsG
1mrna length is 606bp.
UnsG
2gene: forward primer 5 ' AGCGAATTCATGTGCGTCCAACACAAGGTG 3 '
Reverse primer 5 ' AGAAAGCTTCTATGCTGCGAAAATGTCGGGG3 '
UnsG
2mrna length is 648bp.
Embodiment 8: " hundred make " produces the preparation of bacterium Cordyceps sinensis China pilose spore cDNA first chain
After the method first provided according to embodiment 1 turns out sutella sinensis fermented mycelium, the method provided according to embodiment 2 again carries out the extraction of total serum IgE to China pilose spore, carry out by following the synthesis that " hundred make " produces bacterium Cordyceps sinensis China pilose spore cDNA first chain, for follow-up each gene clone experiment after obtaining total serum IgE.
Adopt PrimeScript 1st Strand cDNA Synthesis Kit test kit (TaKaRa) reverse transcription synthesis cDNA first chain from Total RNA, experimental procedure is as follows:
1) in Microtube pipe, following mixed solution is prepared.
2) sex change, annealing operation are conducive to the sex change of template ribonucleic acid and the specificity annealing of reverse transcription primer and template, and can improve reverse transcription reaction efficiency, so carry out sex change, annealing reaction in PCR instrument, condition setting is as follows:
65℃，5 min
3) annealing terminates the rear centrifugal several seconds mixed solution of template ribonucleic acid/primer etc. is gathered in bottom Microtube pipe.
4) in above-mentioned Microtube pipe, following inverse transcription reaction liquid is prepared.
5) in PCR instrument, reverse transcription reaction is carried out by following condition.
42℃ 15～30 min
70℃ 15 min
Generalized case, a PolyA structure is had at eukaryote mRNA 3 ' end, the quantity of A base is not at ten to hundreds of etc., utilize this structure can utilize Oligo (dT) primer, under the effect of ThermoScript II, take mRNA as templated synthesis cDNA first chain, the present invention adopts the sequence in the dT region developed alone by TaKaRa (providing in PrimeScript 1st Strand cDNA Synthesis Kit) to be primer, if the mRNA integrity obtained is better, cDNA first chain of all zymoprotein encoding genes in species so can be obtained by process of reverse-transcription.
Embodiment 9: " hundred make " produces the detection of the clone of bacterium Cordyceps sinensis China pilose spore anabolism docosahexenoic acid functional gene n-Hexadecane Co A hydrolase unsG gene, expression and protein vigor
1, the pcr amplification of n-Hexadecane Co A hydrolase unsG gene
With cDNA first chain obtained in embodiment 8 for template, with the unsG of synthesis in embodiment 7
1gene primer: 5 '-ATA GAA TTC ATG GTG AAT GCG CGG CAG CC3 ' and 5 ' ATA AAG CTT TCA CCG CCC TGC GCT GCC C-3 ', unsG
2gene primer: 5 '-AGC GAA TTC ATG TGC GTC CAA CAC AAG GTG-3 ' and 5 '-AGA AAG CTT CTA TGC TGC GAA AAT GTC GGG G-3 ' carries out Pfu archaeal dna polymerase pcr amplification reaction, and condition setting is as follows:
Pfu pcr amplification reaction system:
Pfu DNA Ploymerase pcr amplification condition:
2, n-Hexadecane Co A hydrolase unsG gene PCR product detected through gel electrophoresis
Concrete detection method is: 1) make it be uniformly dissolved the sepharose microwave-oven-heating of prepare 0.9%; 2) get 15mL gel, when gel is cooled to about 50 DEG C, add 1 μ L staining fluid Gold view, pour into after mixing on treatments of Electrophoretic Slab Gels, after removing bubble, insert point sample comb; 3), after gel sets, the careful point sample that takes out is combed, and offset plate is put into electrophoresis chamber (loading wells one end is near the negative pole of electrophoresis chamber), adds TAE electrophoretic buffer in electrophoresis chamber; 4) get 5 μ L samples and then add 6 × Loading Buffer 1.5 μ L and ddH
2o 4 μ L uses liquid-transfering gun loading after mixing, and applied sample amount is 10 μ L; 5) connect the supply lead between electrophoresis chamber and electrophoresis apparatus, just very red, negative pole is black; 6) power-on, start electrophoresis, maximum voltage is no more than 5 V/cm; 7) electrophoresis can be stopped when sample ran 2/3 of offset plate; 8), after cutting off the electricity supply, gel taken out and puts into the observation of gel imaging instrument, take pictures.
Transcript profile order-checking prediction n-Hexadecane Co A hydrolase unsG
1the size of gene is 606bp, unsG
2the size of gene is 648bp, and agarose gel electrophoresis result shows that Successful amplification has gone out n-Hexadecane Co A hydrolase unsG
1the size of gene is about 600bp, unsG
2the size of gene is about 650bp.Fig. 5 is that " hundred make " produces bacterium China pilose spore anabolism docosahexenoic acid functional gene PCR primer gel electrophoresis figure.
3, n-Hexadecane Co A hydrolase unsG gene PCR product add base A process and purifying
Because Pfu archaeal dna polymerase PCR primer end is flush end, connect so just can be used for carrier T also need to carry out adding base A process, purifying after glue reclaims after.It is as follows that glue recovery product adds base A system:
In PCR instrument, 72 DEG C add A base 20 min, finally purify with AxyPrep PCR cleaning agents box.
4, the connection of n-Hexadecane Co A hydrolase unsG gene and cloning vector
Cloning vector pMD18-T Vector is purchased from TaKaRa company (TaKaRa code D101A), and its physical map is shown in Fig. 6, by n-Hexadecane Co A hydrolase unsG
1, unsG
2gene is connected construction recombination plasmid pMD18-T/unsG with cloning vector
1and pMD18-T/unsG
2, physical map is shown in Fig. 7, linked system and condition of contact as follows.
Linked system:
Condition of contact: 16 DEG C, 16h; Deactivation: 65 DEG C, 15min.
5, n-Hexadecane Co A hydrolase recombinant plasmid pMD18-T/unsG
1and pMD18-T/unsG
2conversion
By recombinant plasmid pMD18-T/unsG
1and pMD18-T/unsG
2proceed to the recombinant bacterium E. coli JM109/pMD18-T/unsG building in intestinal bacteria E. coli JM109 and carry n-Hexadecane Co A hydrolase unsG gene respectively
1with E. coli JM109/pMD18-T/unsG
2, concrete steps are: 1) go in competent cell E. coli JM109 by 10 μ L reaction systems, ice bath 30min; 2) thermal shock: 42 DEG C, 90s; 3) ice bath: 2-3min; 4) 800 μ L liquid LB are added, 37 DEG C, 250rpm, 1h; 5) spread plate (containing Amp resistance); 6) 37 DEG C of incubator overnight incubation.
6, n-Hexadecane Co A hydrolase E. coli JM109/pMD18-T/unsG
1with E. coli JM109/pMD18-T/unsG
2the screening of positive recombinant bacterium
Bacterium colony PCR can extract genomic dna, and directly with the DNA exposed after thalline pyrolysis for template carries out pcr amplification, the method is easy and simple to handle, quick, can Rapid identification bacterium colony be whether positive bacterium colony containing object plasmid, comparatively common in conversion qualification.In experiment, carrying out bacterium colony PCR by being inoculated into single bacterium colony corresponding in liquid nutrient medium, whether proceeding to goal gene to verify.First, add in the 1.5mL centrifuge tube containing 50 μ L sterilized waters with toothpick picking list bacterium colony, boiling water bath 30min, then centrifugal using supernatant as template, carry out pcr amplification, PCR program setting is Taq enzyme amplification general procedure.The agarose gel electrophoresis of 0.9% is finally adopted to detect bacterium colony PCR primer.
7, the order-checking of n-Hexadecane Co A hydrolase recombinant plasmid pMD18-T/unsG
After the positive recombinant bacterium LB liquid medium overnight incubation that bacterium colony PCR is detected, get 4mL bacterium liquid and extract plasmid, the operation instructions that method provides by AxyPrep plasmid DNA small volume of reagent box.Order-checking is completed by Sani bio tech ltd, Shanghai.Through sequence verification, sequence SEQ ID No.2 and SEQ ID No.4 is to recombinate to pMD18-T/unsG respectively
1and pMD18-T/unsG
2in.
8, n-Hexadecane Co A hydrolase recombinant expression plasmid pET-28a/unsG
1and pET-28a/unsG
2structure
Experimental basis foreign gene is in the principle of expression in escherichia coli, and expression vector pET-28a and n-Hexadecane Co A hydrolase unsG gene restriction enzyme site comparison situation, determine EcoR I and Hind III double enzyme site, and to recombination bacillus coli E. coli JM109/pMD18-T/unsG
1with E. coli JM109/pMD18-T/unsG
2carry out the cultivation of liquid LB test tube shaker, recombinant plasmid extraction respectively.
The recombinant plasmid pMD18-T/unsG of n-Hexadecane Co A hydrolase unsG gene
1and pMD18-T/unsG
2and expression vector pET-28a use respectively EcoR I/Hind III restriction enzyme 37 DEG C respectively enzyme cut process 6h, it is as follows that enzyme cuts system:
EcoR I/Hind III double digestion system:
Enzyme is cut and is terminated rear 65 DEG C of deactivation 15min, then respectively with Axygen DNA gel recovery test kit carry out reclaiming, purifying.
N-Hexadecane Co A hydrolase unsG gene and expression vector pET-28a connect with T4 ligase enzyme 16 DEG C again and spend the night after double digestion, purifying, and build recombinant expression plasmid, its building process is shown in Fig. 8, build the recombinant expression plasmid pET-28a/unsG obtained
1, pET-28a/unsG
2fig. 9 is shown in by collection of illustrative plates.Linked system is composed as follows:
Linked system:
9, n-Hexadecane Co A hydrolase recombinant expression plasmid pET-28a/unsG
1and pET-28a/unsG
2conversion and the screening of positive monoclonal
By heat-shock transformed in E. coli BL21 Host Strains for the expression plasmid built, be then applied on the LB agar plate containing kantlex (Kan) resistance, 37 DEG C of overnight incubation.From flat board, random choose list bacterium colony, carries out pcr amplification with the primer of each functional gene, selects positive colony.
10, the abduction delivering of n-Hexadecane Co A hydrolase recombinant bacterium
The mono-clonal being accredited as the positive is inoculated in 5mL to be contained in the LB liquid nutrient medium of Kan resistance, 37 DEG C, 250r/min overnight incubation.Get 1mL culture, transferred in 50mL to contain in the LB liquid nutrient medium of Kan resistance 37 DEG C, 250r/min is cultured to cell concentration OD600 and is about about 0.6 ~ 0.8.Certain density IPTG inducing culture 8h is added respectively in culture.Collect thalline for electrophoretic analysis and Enzyme activity assay.
11, n-Hexadecane Co A hydrolase recombinant bacterium expression product SDS-PAGE analyzes
With the E. coli BL21 bacterium proceeding to empty carrier and do not add inductor IPTG recombinant bacterium in contrast.Be accredited as positive recombinant bacterium after IPTG inducing culture certain hour, get 0.5mL Induced cultures, collected by centrifugation thalline, be resuspended in 50 μ L distilled water, add 50 μ L sample-loading buffers, boil 10min after mixing, carry out SDS-PAGE electrophoretic analysis, " A " swimming lane in Figure 10 is recombinant bacterium E. coli BL21/pET-28a/unsG
1the n-Hexadecane Co A hydrolase unsG expressed
1the SDS-PAGE figure of (through its aminoacid sequence of sequence verification as shown in SEQ ID No.1), " B " swimming lane is recombinant bacterium E. coli BL21/pET-28a/unsG
2the n-Hexadecane Co A hydrolase unsG expressed
2the SDS-PAGE figure of (through its aminoacid sequence of sequence verification as shown in SEQ ID No.3).
12, the protein-active of n-Hexadecane Co A hydrolase recombinant bacterium detects
(1) n-Hexadecane Co A hydrolase unsG
1protein-active detect:
Prepared by enzyme liquid: the recombinant bacterium E. coli BL21/pET-28a/unsG taking collection
10.5g phosphate buffered saline buffer (50mM, pH8.0) 15mL suspends, ultrasonication (power 350W, broken 2s, interval 2s, altogether ultrasonication 5min).
N-Hexadecane Co A hydrolase unsG
1transformation system: transform in bottle at 50mL and add E. coli BL21/pET-28a/unsG
1ultrasonication thalline 10mL, 0.1g bis-dodecahexaene coenzyme A, 30 DEG C, 150r/min transforms, transform after terminating, centrifuging and taking supernatant is standby with subsequent detection.
Detection method: GC conditions: 30m × 0.32mm × 0.25mm fused-silica capillary column; Post initial temperature post initial temperature 190 DEG C, insulation 1min, is warming up to 230 DEG C with 6 DEG C/min, then constant temperature; Vaporizer temperature 250 DEG C; Carrier gas is high-purity He (99.999%); Pressure 62.6KPa before post; Flow rate of carrier gas 1.4mL/min; Sample size 1 μ L; Splitting ratio 60:1.Mass Spectrometry Conditions: ion source is EI source; Ion source temperature 230 DEG C; Quadrupole temperature 150 DEG C; Electron energy 70eV; Interface temperature 260 DEG C; Solvent delay 2min; Mass range 10-550u.
Detect through above-mentioned chromatographic condition and calculate, draw to draw a conclusion: n-Hexadecane Co A hydrolase recombinant bacterium E. coli BL21/pET-28a/unsG
1the high specific enzyme (Specific Activity) alive of expressed n-Hexadecane Co A hydrolase is 320 mol/min/mg, and substrate conversion efficiency is 80.73%.
(1) n-Hexadecane Co A hydrolase unsG
2protein-active detect:
Prepared by enzyme liquid: the recombinant bacterium E. coli BL21/pET-28a/unsG taking collection
20.5g uses phosphate buffered saline buffer (50mM, pH8.0) 15mL to suspend respectively, ultrasonication (power 350W, broken 2s, interval 2s, altogether ultrasonication 5min).
N-Hexadecane Co A hydrolase unsG
2transformation system: transform in bottle at 50mL and add E. coli BL21/pET-28a/unsG
2ultrasonication thalline 10mL, 0.1g bis-dodecahexaene coenzyme A, 30 DEG C, 150r/min transforms, transform after terminating, centrifuging and taking supernatant is standby with subsequent detection.
Detection method: GC conditions: 30m × 0.32mm × 0.25mm fused-silica capillary column; Post initial temperature post initial temperature 190 DEG C, insulation 1min, is warming up to 230 DEG C with 6 DEG C/min, then constant temperature; Vaporizer temperature 250 DEG C; Carrier gas is high-purity He (99.999%); Pressure 62.6KPa before post; Flow rate of carrier gas 1.4mL/min; Sample size 1 μ L; Splitting ratio 60:1.Mass Spectrometry Conditions: ion source is EI source; Ion source temperature 230 DEG C; Quadrupole temperature 150 DEG C; Electron energy 70eV; Interface temperature 260 DEG C; Solvent delay 2min; Mass range 10-550u.
Detect through above-mentioned chromatographic condition and calculate, draw to draw a conclusion: n-Hexadecane Co A hydrolase recombinant bacterium E. coli BL21/pET-28a/unsG
2the high specific enzyme (Specific Activity) alive of expressed n-Hexadecane Co A hydrolase is 308mol/min/mg, and substrate conversion efficiency is 79.69%.
Claims (5)
1. participate in a n-Hexadecane Co A hydrolase for two dodecahexaene coenzyme A anabolism docosahexenoic acids, it is characterized in that the aminoacid sequence of described n-Hexadecane Co A hydrolase is as shown in SEQ ID No.1.
2. n-Hexadecane Co A hydrolase as claimed in claim 1 prepares the application in docosahexenoic acid at biocatalysis two dodecahexaene coenzyme A.
3. the gene of n-Hexadecane Co A hydrolase described in coding claim 1.
4. gene as claimed in claim 3, is characterized in that the nucleotide sequence of described gene is as shown in SEQ ID No.2.
5. gene as claimed in claim 3 is building and can prepare application in the genetic engineering bacterium of docosahexenoic acid by biocatalysis two dodecahexaene coenzyme A.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210492892.2A CN103013946B (en) | 2012-11-09 | 2012-11-09 | Cordyceps sinensis hexadecane coenzyme A hydrolytic enzyme, gene and applications of hydrolytic enzyme and gene |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210492892.2A CN103013946B (en) | 2012-11-09 | 2012-11-09 | Cordyceps sinensis hexadecane coenzyme A hydrolytic enzyme, gene and applications of hydrolytic enzyme and gene |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103013946A CN103013946A (en) | 2013-04-03 |
| CN103013946B true CN103013946B (en) | 2015-01-28 |
Family
ID=47963061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210492892.2A Active CN103013946B (en) | 2012-11-09 | 2012-11-09 | Cordyceps sinensis hexadecane coenzyme A hydrolytic enzyme, gene and applications of hydrolytic enzyme and gene |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103013946B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102373190A (en) * | 2011-09-09 | 2012-03-14 | 浙江工业大学 | Relevant enzymes for preparing mannitol by performing anabolism on Chinese caterpillar fungus and hirsutella sinensis, gene and application thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101899411B (en) * | 2009-08-12 | 2012-02-29 | 青岛生物能源与过程研究所 | Engineering escherichia coli for preparing medium-carbon fatty alcohol |
| CN102690801B (en) * | 2012-05-28 | 2014-07-02 | 浙江工业大学 | Enzyme for synthesizing and metabolizing inosine monophosphate of Cordyceps sinensis(Berk.)Sacc. Hirsutella sinensis and application thereof |
-
2012
- 2012-11-09 CN CN201210492892.2A patent/CN103013946B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102373190A (en) * | 2011-09-09 | 2012-03-14 | 浙江工业大学 | Relevant enzymes for preparing mannitol by performing anabolism on Chinese caterpillar fungus and hirsutella sinensis, gene and application thereof |
Non-Patent Citations (3)
| Title |
|---|
| acyl-CoA thioesterase;Zheng P et al.;《GenBank: EGX94890.1》;20120504;1 * |
| Genome sequence of the insect pathogenic fungus Cordyceps miitaris, a valued traditional Chinese medicine;Zheng P et al.;《Genome Biol》;20111123;第12卷(第11期);1-21 * |
| 工程大肠杆菌脂肪酸胞外分泌调控研究进展;孟鑫等;《食品科学》;20110315;第32卷(第5期);331-335 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103013946A (en) | 2013-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103087998B (en) | Enzyme for synthesizing cetyl-coenzyme A through cordyceps sinensis, gene and application thereof | |
| CN103031285B (en) | Cordyceps Chinese Hirsutella uridine-cytidine kinase, coding gene and application thereof | |
| CN103031295B (en) | Cordyceps cytidine deaminase, coding gene and application thereof | |
| CN102978177B (en) | Cordyceps sinensis delta-5-desaturase used in anabolism of eicosapentaenoic acid, and gene and application thereof | |
| CN102747057B (en) | Cordyceps sinensis hirsutella sinensis purine anabolism enzyme, gene thereof, and application thereof | |
| CN103013946B (en) | Cordyceps sinensis hexadecane coenzyme A hydrolytic enzyme, gene and applications of hydrolytic enzyme and gene | |
| CN103074311B (en) | Enzyme of Cordyceps hirsutella sinensis for synthesis of acetic acid, and gene and application thereof | |
| CN102965351B (en) | Cordyceps sinensis omega-6 fatty acid-dehydrogenase, gene and application of gene | |
| CN102965350B (en) | Cordyceps sinensis stearoyl-CoA desaturase, gene and application of gene | |
| CN103031286B (en) | Cordyceps Chinese Hirsutella uridylate-cytidylate kinase, coding gene and application thereof | |
| CN103074308B (en) | Enzyme of Cordyceps hirsutella sinensis for synthesis of 3-hydroxybutyrate, and gene and application thereof | |
| CN104120112B (en) | Cordyceps sinensis 3-Isopropylmalate dehydrogenase B, encoding gene and application thereof | |
| CN103031287B (en) | Cordyceps Chinese Hirsutella nucleoside diphosphokinase, coding gene and application thereof | |
| CN104388400B (en) | Enzyme and gene of cordyceps sinensis hirsutella sinensis synthesized acetic acid and application thereof | |
| CN103045557B (en) | Cordyceps sinensis China pilose spore nucleosidetriphosphate pyrophosphatase, encoding gene and application | |
| CN104120113B (en) | Cordyceps 3-Isopropylmalate dehydrogenase C, encoding gene and application thereof | |
| CN103031280B (en) | Cordyceps sinensis CTP synthetic enzyme, encoding gene and application thereof | |
| CN103031296B (en) | Cordyceps sinensis dCMP (Deoxycytidine Monophosphate) deaminase, encoding gene and application of cordyceps sinensis dCMP deaminase | |
| CN103045573B (en) | Cordyceps sinensis cytosine deaminase, coding gene and application thereof | |
| CN103031281B (en) | Cordyceps Chinese Hirsutella carbamyl phosphate synthetase, coding gene and application thereof | |
| CN104120114B (en) | Cordyceps 3-Isopropylmalate dehydrogenase A, encoding gene and application thereof | |
| CN103031288A (en) | Cordyceps Chinese Hirsutella 5'-nucleotidase, coding gene and application thereof | |
| CN103031284B (en) | Cordyceps thymidylate synthetase, coding gene and application thereof | |
| CN104651324A (en) | CTP (Cytidine Triphosphate) synthetase of cordyceps sinensis, coding gene and application of CTP synthetase | |
| CN103045550A (en) | Cordyceps sinensis hirsutella sinensis dihydroorotate oxidase, coding gene and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |